The Union Health Ministry on Thursday 13th May raised the gap between the two doses of Covishield COVID-19 vaccine to 12-16 weeks from the earlier 6-8 weeks based upon the recommendation of National Covid Team- the Union Health Minister said on Thursday in a Press Briefing. On the other hand no changes have been done to Covaxin , which remains at four to six weeks.
AstraZeneca Vaccine under the brand name of Covishield is manufactured and distributed by Serum Institute of India (SII).
#Covishield वैक्सीन की पहली और दूसरी डोज़ के बीच के अंतर को 12-16 हफ़्ते तक बढ़ा दिया गया है। इससे पहले अभी तक कोविशील्ड वैक्सीन की दो डोज़ के बीच का अंतर 6-8 हफ़्ते का था।कोविड वर्किंग ग्रुप की सिफ़ारिश के बाद यह फ़ैसला किया गया है।@PMOIndia #vaccinated pic.twitter.com/3KoqxsGe3Y
— Dr Harsh Vardhan (@drharshvardhan) May 13, 2021
What the National Covid Team Recommended
-Enhance the gap in between 2 dosages of Serum Institute of India’s Oxford Covid-19 vaccination ‘Covishield’ to 12-16 weeks, a government panel had actually suggested. Presently, the period in between 2 dosages of Covishield is 4 to 8 weeks. Those that have actually checked favorable for Covid-19 and also are waiting to take the vaccination needs to postpone inoculation for 6 months after recuperation, the National Technical Advisory Group on Immunisation (NTAGI) advised.
The Govt clarified that this decision has been taken from the real life evidence from United kingdom the Covid-19 Working Team concurred for boosting the application period to 12-16 weeks in between 2 dosages of Covishield vaccination.
Experts explained that the choice can be caused by the injection scarcity, as opposed to any type of clinical reasoning.
Currently, the advised space in between 2 dosages of Covishield in India is 4-8 weeks despite the fact that the WHO had in February advised carrying out both dosages of the vaccination at a void of 12 weeks, mentioning proof which revealed that its efficiency of the vaccination is the highest possible following this period.